Related Experiment Video
Updated: Aug 2, 2025

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
Published on: August 26, 2013
Increased BMP-Smad signaling does not affect net bone mass in long bones.
Maiko Omi1, Tejaswi Koneru1, Yishan Lyu1
1Department of Biologic and Materials Sciences and Prosthodontics, University of Michigan School of Dentistry, Ann Arbor, MI, United States.
Altering bone morphogenetic protein (BMP) signaling in osteoblasts does not impact adult bone mass. This suggests BMPs may be safely used in clinical settings, despite potential side effects.
Area of Science:
- Skeletal Biology
- Molecular Endocrinology
- Bone Physiology
Background:
- Bone morphogenetic proteins (BMPs) are used for orthopedic and dental applications due to osteoinductive properties.
- Adverse reactions like heterotopic bone formation and increased cancer risk necessitate understanding BMPs' tissue-specific functions.
- Previous studies indicated BMP signaling in osteoblasts influences osteoclast function and bone resorption.
Purpose of the Study:
- To investigate the impact of varying bone morphogenetic protein receptor type IA (BMPR1A) signaling levels in osteoblasts on bone phenotype.
- To determine how altered BMP signaling activity in osteoblasts affects bone mass and resorption in adult mice.
- To provide insights into the clinical application of BMPs by understanding their effects in a controlled context.
Main Methods:
- Utilized Osterix-Cre transgenic mice with heterozygous null (Bmpr1a+/-) and homozygous constitutively active (caBmpr1a-/-) mutations for BMPR1A in osteoblasts.
- Analyzed tibiae of 3-month-old mice using micro-CT and histological analysis.
- Performed gene expression analysis to assess bone formation/resorption markers and BMP-Smad signaling pathway activity.
Main Results:
- No significant overt bone phenotypes were observed in the tibiae of Bmpr1a+/-, caBmpr1a-/-, or caBmpr1a-/- mice compared to controls.
- BMP-Smad signaling was increased in caBmpr1a-/- mice and decreased in Bmpr1a+/- mice, confirming altered signaling activity.
- Gene expression showed slight increases in bone formation and resorption markers, but no significant changes in TRAP-positive cells, indicating no net effect on bone turnover.
Conclusions:
- Modulating BMPR1A signaling activity within differentiating osteoblasts does not alter net bone mass in adult mice.
- These findings suggest that targeted BMP signaling in osteoblasts may not lead to significant skeletal changes, potentially mitigating concerns about clinical applications.
- The study provides crucial insights into the context-dependent roles of BMP signaling, informing the safe use of BMPs in therapeutic settings.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
TGF - β Signaling Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The JAK-STAT Signaling Pathway
Osteoclasts in Bone Remodeling